Dr Annalisa Morgan reflects on new data on DMTs for RRMS that highlighted the potential of BTK inhibitors such as ...
A new analysis provides substantial evidence that paramagnetic rim lesions drive disability in MS and are targetable with a ...
Tolebrutinib had the most protective effect against disability worsening at 6 months in patients with multiple sclerosis who had a greater number of MRI paramagnetic rim lesions at baseline, data show ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback